News – Page 830 – Endpoints News

Days after Intercept rejection, Akero surges on ‘unprecedented‘ NASH data

5 years ago

Covid-19 has roiled clinical trial plans around the world, raising concerns over the industry’s future on new drug ...

5 years ago

An experienced biotech is stitched together from transpacific parts, with 265 staffers and a focus on ‘new ...

5 years ago

New standard of care? FDA hands Pfizer, Merck KGaA an OK for Bavencio in bladder cancer

5 years ago

Rubius marks milestone in PhI/II as CFO departs; Owkin closes $70M Series A; The Carlyle Group bets on Indian CDMO

5 years ago

Gilead-partnered Goldfinch Bio lands $100M as it pivots to clinical stage biotech

5 years ago

Covid-19 roundup: Vaccines will need to beat placebo by 50% to qualify for FDA OK; UK trial drops Kaletra

5 years ago

Elias Zerhouni discusses ‘amateur hour’ in DC, the destruction of infectious disease R&D and how we need to prep ...

5 years ago

Zynerba flunks another major trial, all but ending Fragile X hopes

5 years ago

Positive Covid-19 vaccine data? New mouse study? OWS inclusion? Yep, but somehow, the usual tidbits from Inovio ...

5 years ago

Takeda maps out a discovery alliance aimed at breaking through the safety and efficacy boundaries that limit the ...

5 years ago

On a roll, Merck blazes through a new segment of the biomarker trail

5 years ago

Freeline nabs $120M, eyes IPO as its gene therapy comes into focus

5 years ago

Seattle Genetics, Genmab turn on TV for a highlight reel in cervical cancer — but a rival biotech promises a better ...

5 years ago

WHO ACT-Accelerator prioritizes global vaccine approach

5 years ago

EMA removes negative note on label of PTC's Duchenne drug; GSK, Akebia win Japan OK for oral anemia drugs

5 years ago

Pharma giants return to antibiotics huddle to launch $1B venture fund — report

5 years ago

Heron earns a second slapdown from the FDA on pain med — shares wither

5 years ago

FDA rejects Intercept’s pitch for NASH as CEO fires back at the agency’s ‘evolving’ guidelines

5 years ago

Kiniksa preps BLA as Regeneron drug cruises to a PhIII win — shares soar

5 years ago

Takeda takes a $200M hit after Novartis is forced to yank its marketing application for Xiidra

5 years ago

Sekar Kathiresan showcases historic monkey data in hunt for a once-and-done gene editing approach to prevent heart ...

5 years ago

The biotech IPO boom is becoming ‘historic’ as four more throw their hats in

5 years ago

Gilead opts for $3,120 US insurer price for Covid-19 drug remdesivir — but some say it should be free

5 years ago

First page Previous page 827 828 829830831 832 833 Next page Last page